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Two Distinct Pathways of B-Cell Development in
Peyer’s Patches
PHILIP J. GRIEBEL," BIRGIT KUGELBERG, and GIORGIO FERRARI
Basel Institute for Immunology, 487-Grenzacherstrasse, Postfach, CH-4005, Basel, Switzerland
The developmental biology of sheep ileal and jejunal Peyer’s patches (PP) was investigated
using corticosteroids to deplete immature B lymphocytes. During a 7-day treatment with
dexamethasone, ileal PP follicular (iPf)B-cell proliferation was arrested and most iPfB-cells
died. This resulted in follicular involution with the survival of mesenchymal cells. No
iPfB-cell proliferation was detected in follicular remnants for 4 weeks postdexamethasone
treatment, and during a subsequent 3-month period, there was limited iPfB-cell prolifera-
tion that resulted in a partial regeneration of follicles. Ileal PP involution was also associated
with a severe B lymphopenia that persisted for over 14 weeks and was characterized by the
survival of primarily isotype-switched and CD5 sIgM B-cells in blood. In contrast, the
size of jejunal PP follicles was reduced following dexamethasone treatment, but intrafolli-
cular B-cell proliferation was not arrested. Furthermore, within 4 weeks, the jejunal PP
follicles had recovered in size and cellularity and there was no disruption in IgA plasma-cell
production. Thus, dexamethasone selectively depleted iPfB-cells and revealed that the ileal
and jejunal PPs contain functionally distinct B-cell populations. The partial regeneration of
the iPfB-cell population indicated that either an intrafollicular, corticosteroid-resistant
B-stem cell existed or that ileal PP follicles can be repopulated by circulating B-cells. Finally,
the association between ileal PP involution and the absence of circulating, CD5- B-cells
confirmed that this lymphoid tissue provides an essential environment for conventional
sIgM B-cell development.
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INTRODUCTION
Investigations in rodents have established the con-
cept that after birth, the bone marrow functions as
the primary site of B-cell generation (Claman et al.,
1966; Mitchell and Miller, 1968; Osmond, 1980),
and investigations in both rodents and rabbits re-
vealed that the Peyer’s patches (PPs) function as a
secondary, antigen-dependent lymphoid tissue that
plays a major role in mucosal immunity (Pollard and
Sharon, 1970; Craig and Cebra, 1971; Husband and
Gowans, 1978). Consistent with this hypothesis,
lymphoid follicles in the PPs develop postnatally in
these species (Hummel, 1935; Waksman et alo, 1973;
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Abe and Ito, 1977). However, in humans (Cornes,
1965), sheep (Reynolds and Morris, 1983), pigs
(Chapman et al., 1974), and other species (Carlens,
1928), the lymphoid follicles of the PPs are well-
developed prior to birth, and in PPs of fetal sheep,
there is a high level of B-cell proliferation (Reynolds
and Morris, 1983). This fetal developmental sug-
gests that B-cell development in the PPs is, to
some extent, antigen-independent and T-cell-
independent. Thus, PPs may function as a site of
both antigen-dependent and antigen-independent
B-cell development.
Located along the small intestine of sheep are two
distinct types of PPs: the ileal PP and the jejunal PP.
These two PPs differ markedly in their life history,
histology, lymphocyte composition, B-cell differen-
tiation, and their role in the development of the
humoral immune system. During ontogeny, lym-
phoid follicles develop first in the jejunal PPs, but in
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late-term fetuses, the follicular B-cells proliferate at MATERIAL AND METHODS
a high level in both PPs (Reynolds and Morris,
1983). However, B-cell development in the two Reagents
PPs appears to diverge at birth (Griebel et al., Dexamethasone (9a-fluoro-16a-methylpredniso-
1992). Jejunal PPs are active throughout the life of lone) was purchased from Sigma (St. Louis);
the animal and are a site for T-cell-dependent 5-bromo-2-deoxyuridine (BrdU)and mouse mono-
antigen responses with the production of both clonal (mAb) anti-BrdU (BMC 9318)were purchased
IgG1 and IgA PCs (Gerber et al., 1986; Griebel from Boehringer-Mannheim (Mannheim, Ger-
and Ferrari, 1995). In contrast, in the ileal PP, the many). The biotinylated-, fluorescein isothiocyanate
production of B-cells (Griebel and Ferrari, 1994) (FITC-), and phycoerythrin (PE-) conjugated,
and diversification of the immunoglobulin (Ig) isotype-specific goat anti-mouse Ig reagents were
receptor repertoire (Reynaud et al., 1995) are purchased from Southern Biotechnology (Birming-
antigen-independent and T-cell-independent and ham, AL). The PE-conjugated rat anti-mouse CD8
the lymphoid follicles involute following sexual was purchased from Caltag (San Francisco). Soluble,
maturity (Reynolds and Morris, 1983). In young recombinant fusion protein of murine CD40L-CD8
sheep, the ileal PP is the primary source of B-cells (mCD40L-CD8; Lane et al., 1993) was a generous
for all lymphoid tissues and provides an essentials gift from Peter Lane (Basel Institute for Immunol-
environment for B-cell development (Gerber et al., ogy, Basel, Switzerland) and was previously shown
1986; Reynolds et al., 1991). to react with sheep CD40 (Griebel and Ferrari,
Immature lymphocytes, such as cortical thymo- 1995). The anti-IgM (PIg45A), anti-IgG1 (Blg715A),
cytes (Ishidate and Metcalf, 1963) and B-cells in anti-IgA (Blg312D3), anti-X Ig LC (Blg501E), and
lymphoid follicles of the chicken bursa of Fabricius anti- Ig LC (Blg43) mAbs were purchased from
(Glick, 1957), display a high corticosteroid sensitiv- VMRD Inc. (Pullman, WA). The pan-B cell (Du2-
ity. In contrast, mature lymphocyte populations in 104; Press et al., 1993), anti-CD4 (17D-13; Maddox
secondary lymphoid tissues are much less sensitive et al., 1985), anti-CD5 (STla; Beya et al., 1986),
to the cytolytic effects of corticosteroid (Cupps and anti-CD8 (E95; Ezaki et al., 1987), anti-,3 T-cell
Fauci, 1982). The sheep ileal PP B-cells display receptor (127; Mackay et al., 1989), anti-CD44 (25-
many of the characteristics of a primary lymphoid 32; Mackay et al., 1988), and anti-CD45R (Mackay
tissue and should display a high corticosteroid et al., 1987) mAbs were obtained from hybridomas
sensitivity relative to other gut-associated lym- maintained at the Basel Institute for Immunology,
phoid tissues. Previous analyses of the V-J junc- Basel. The anti-vimentin (VIM13.2)mAb was pur-
tional diversity of rearranged Ig light-chain (LC) chased from Sigma and the rabbit anti-human CD3
genes suggested that the B-cell population in each was purchased from Dakopatts (Glostrup, Den-
ileal PP follicle was oligoclonal, arising from a mark).
limited number of B-cell immigrants during fetal
development (Reynaud et al., 1991). In vivo (Rey-
Animals and Dexamethasone Treatment nolds, 1986) and in vitro (Griebel and Ferrari,
1994) analyses of iPfB-cell production and death All experiments were conducted using 4-5-week-
further support the idea that a closed population old suckling lambs or 144-day gestation (148-day
of iPfB-cells is maintained by self-renewing pro- gestation period) fetuses, of either sex (Versuchbe-
liferation. Therefore, it was postulated that if trieb Sennweid, Olsburg, Switzerland). Dexametha-
corticosteroid treatment induced B-cell death and sone was dissolved in dimethysulfoxide (Fulka
arrested proliferation, then follicular involution Chemie, Fuchs, Switzerland) and prior to intrave-
should follow. A dexamethasone-treatment proto- nous (iv) injection diluted to a final concentration of
col was developed that induced thymic involution 1 mg/ml in 37C phosphate-buffered saline (PBS).
and arrested B lymphopoiesis in the ileal PP of Six groups of lambs were used for dexamethasone
young sheep. The consequences of dexamethasone treatment: 3 lambs were used to investigate the
treatment were then compared for the ileal and response of ileal PP follicles and the thymus to 0.02,
jejunal PPs that contain functionally and pheno- 0.2, and 2.0 mg dexamethasone/kg body weight
typically distinct B-cell populations (Hein et al., (BW) injected for 3 consecutive days; 3 lambs were
1989; Griebel and Ferrari, 1995). used to evaluate the response of ileal PP follicles andB-CELL DEVELOPMENT IN PEYER’S PATCHES 265
the thymus to dexamethasone following daily injec-
tions of 2 mg/kg BW for 3, 5, or 7 days; 4 groups of
4 lambs were used to evaluate the responses of the
PPs, thymus, and blood lymphocyte populations
following daily injections of 2 mg/kg BW dexa-
methasone for 7 consecutive days. One group of 4
lambs was used to study the responses of lymphoid
tissues during each of the following posttreatment
intervals: days 1-10; days 1-28; days 1-52; and
days 1-98.
of 20 mg/kg BW 30 min prior to collecting tissues.
This procedure resulted in a detectable level of BrdU
incorporation in 40-45% iPfB-cells and 8-10% of
thymocytes (Griebel and Ferrari, 1995). Immuno-
peroxidase detection of BrdU incorporated in tissue
sections was performed as previously described
(Griebel and Ferrari, 1994).
RESULTS
Tissue Collection, Cell Isolation,
Immunohistochemistry (IHC), and Flow
Cytometry
Blood collected in EDTA was used to determine total
white cell counts, differential counts of leukocytes,
and to isolate mononuclear cells with a discontinu-
ous Percoll gradient (Griebel and Ferrari, 1995). Cell
suspensions were prepared from lymphoid follicles
of the PP and other tissues as described previously
(Griebel and Ferrari, 1995; Griebel et al., 1994).
Tissues for histology were first fixed in phosphate-
buffered formaldehyde (12%) prepared in methanol
and then dehydrated in graded ethanol before em-
bedding in Technovit 7100 medium (Heraeus
Kulzer, Wehrheim, Germany). Tissue sections, 1-1.5
m thick, were mounted on precleaned glass slides,
heated at 70C for 1 hr and then stained for 3 min
with 1% threonine-acetate (Fluka) prepared in dis-
tilled H20. Tissues for IHC were placed in cryo-
molds (Tissue-Tek II; Lab-Tek Products, Nunc Inc.,
Naperville, IL) and mucosal surfaces were covered
with a thin slice of liver before embedding in O.C.T.
compound (Miles Lab. Inc., Naperville, IL) and
freezing on dry ice. The methods for indirect label-
ing of cell suspensions for flow cytometric analysis
(FACScan; Becton Dickinson, Mountain View, CA),
cell sorting (FACStar Plus, Becton Dickinson), and
indirect immunoperoxidase staining of frozen tissue
sections have previously been described in detail
(Griebel et al., 1994; Griebel and Ferrari, 1995). To
quantitate lymphocyte subpopulations in blood, the
total number of blood mononuclear cells/ml blood
was multiplied by the percent mononuclear cells
labeled by the appropriate mAb and detected with
flow cytometric analyses.
BrdU Incorporation and Detection
BrdU was dissolved in 60C PBS, cooled to room
temperature, and injected iv at a final concentration
Dexamethasone-Induced Involution of Primary
Lymphoid Tissues
Preliminary experiments were completed to deter-
mine if dexamethasone induced involution of pri-
mary lymphoid tissues in young lambs. The thymus
was used as a control organ because of its well-
characterized corticosteroid sensitivity in mice (Ishi-
date and Metcalf, 1963; Clamen et al., 1971). The
effect of dexamethasone treatment on the thymus
and ileal PP was first evaluated with 0.02, 0.2, and
2 mg dexamethasone/kg BW administered for 3
consecutive days. Ileal PP histology and thymic
weights were evaluated with tissues collected 24 hr
after the last treatment. A marked reduction in
thymic weight (40-60% decrease) and ileal PP
follicular size and cellularity was observed at all
doses of dexamethasone, but with 2 mg/kg, few
follicular B cells were seen on tissue sections (data
not shown). Three lamb were then injected with 2
mg dexamethasone/kg BW for 3, 5, and 7 days, and
tissues were collected 24 hr after each treatment and
30 min after injecting BrdU. Few BrdU cells were
detected in ileal PP follicles following dexametha-
sone treatment for 3 days, and no detectable BrdU
incorporation was observed following the 7-day
treatment (data not shown). Thus, a 7-day treatment
with 2 mg dexamethasone/kg BW was chosen to
study the long-term effects of arrested iPfB-cell
proliferation. This dexamethasone treatment regime
resulted in a marked reduction in thymic cortex with
a relative increase in the medullary region (Fig. lb),
but did not arrest proliferation of cortical thymo-
cytes (Fig. 2b). Thymic weights for untreated, age-
matched lambs were 58.6 + 7.2 g (mean + S.D. of
values from 5 lambs), but during the first 2 weeks
postdexamethasone, the average thymic weights
were 12.8 + 3.2 g (n 5 lambs). The effects of
dexamethasone on thymic architecture and thymo-
cyte proliferation were no longer evident 4-5 weeks
posttreatment (Fig. 2c).266 P.J. GRIEBEL et al.
FIGURE 1. The histology of the thymus, jejunal PP, and ileal PP are compared for age-matched untreated (control) lambs and lambs
treated for 7 days with 2 mg dexamethasone/kg BW (dex). Thymus: a (control) and b (dex) with the cortex (c) and medulla (m)
indicated. Jejunal PP: c (control) and d (dex) with the lymphoid follicles (f), dome region (d), interfollicular area (if), and lymphatic
sinuses (s) indicated. Ileal PP: e (control) and f (dex) with lymphoid follicles (f), dome region (d), interfollicular area (if), and lymphatic
sinuses (s) indicated. Ileal PP follicle: g (control) and h (dex) with the follicular capsule (cs) and "nests" of lymphocytes (closed
triangles) distributed among nonlymphoid stromal cells (open triangles) indicated. Magnification: a-f (bar [in a] 300 m); g and h (bar
[in h] 20 gm).
Depletion of Ileal and Jejunal PP Follicles
Normal ileal PP follicles are enclosed by a thin
fibrous capsule (2-3 cells thick), and in the outer
follicle, there are numerous "nests" of lymphocytes
distributed among nonlymphoid stromal cells (Fig.
l g). The majorityof lymphocytes in the outer folli-
cle incorporate BrdU during a 30-min period (Fig.
2g). Dexamethasone treatment for 7 days resulted
in a dramatic decrease in ileal PP follicular size
(>90%) that was also associated with a reduction
in the size and cellularity of the dome and interfol-
licular regions (Fig. lf). Follicular remnants were
suspended within dilated lymphatic sinuses (Fig.
lf) and no cell proliferation could be detected in
the follicular remnants following BrdU injection
(Fig. 2h). The capsule of involuted follicles was
thickened and disorganized, lymphocytes were
absent within the follicle, but there were many
stromal cells with large nuclei and abundant, vacu-
olated cytoplasm (Fig. lh). IHC confirmed that
most cells within the follicular remnants were mes-
enchymal cells (Fig. 3a), including numerous mac-
rophages (Fig. 3b). A small number of CD4 T-
cells (Fig. 3c) and CD45R cells (Fig. 3d) were also
detected within follicular remnants. The IHC stain-
ing for sIgM B-cells was difficult to interpret be-
cause an intense reticular staining pattern,
suggestive of extracellular Ig, was observed within
follicular remnants. Dexamethasone treatment also
reduced the size and cellularity of the jejunal PP
follicles but did not deplete intrafollicular lympho-
cytes (Fig. ld) and did not arrest the proliferation
of these cells (Fig. 2e). Thus, dexamethasone treat-
ment selectively depleted most iPfB-cells, but many
stromal cells, macrophages, and some CD4 T-
cells survived.B-CELL DEVELOPMENT IN PEYER’S PATCHES 267
FIGURE 2. Cell proliferation, detected by BrdU incorporation, was analyzed in the thymus, jejunal PP, and ileal PP for age-matched,
untreated lambs (control) and for lambs day (D.lpostdex) and 3 weeks (D.21postdex) after treatment for 7 days with 2 mg
dexamethasone/kg BW. Thymus: a (control), b (D.lpostdex), and (D.21postdex) with the cortex (c) and medulla (m) indicated.
BrdU incorporation was evident in the cortex both before and after dexamethasone treatment. Jejunal PP: d (control) and e
(D.lpostdex), and f (D.21postdex) with the lymphoid follicles (f), dome region (d), and interfollicular area (if) indicated. BrdU
incorporation was prominent in the crypt epithelium and lymphoid follicles both before and after dexamethasone treatment. Ileal PP:
g (control), h (D.lpostdex), and (D.21postdex) with lymphoid follicles (f) dome region (d), interfollicular area (if), and muscularis
(ms) indicated. No BrdU incorporation was detected within the follicles following dexamethasone treatment, but BrdU incorporation
in the crypt epithelium remained unchanged. Magnification: a-i (bar [in a] 350 tm).
Differential Regeneration of Ileal and Jejunal
PP Follicles
Ileal PP follicles are characterized by a high mitotic
rate, 15-20x greater than that of the thymus
(Reynolds, 1987). This B-cell proliferation occurs
primarily in the outer follicle with few cells prolif-
erating in the central follicle, dome region, or inter-
follicular region (Fig. 2g). Thus, BrdU incorporation268 P.J. GRIEBEL et al.
FIGURE 3. Immunohistochemical
characterization of cells in ileal PP
lymphoid follicles following treat-
ment with 2 mg dexamethasone/kg
BW for 7 days. a: The stain for mes-
enchymal cells (vimentin) revealed a
network of cells in the lamina propria
of the villi, numerous cells within the
dome (d) and interfollicular region
(if), the majority of cells within the
follicular remants (f), and cells scat-
tered throughout the muscularis (ms).
b: The stain for macrophages (Du2-
66) revealed scattered cells (solid tri-
angles) in the dome region (d) and
many cells (solid triangles) scattered
throughout the follicular remnants
(f). c: The stain for CD4 T cells
revealed cells scattered throughout
the lamina propria, interfollicular re-
gion (if), dome (d), and rare cells
(solid triangles) within the follicular
remnant (f). d: The stain for B cells
(CD45R) revealed numerous cells
within the dome (d), few cells in the
interfollicular region (if), and rare
cells (solid triangles) surviving within
the follicular remnant (f). Magnifica-
tion: a-d (bar [in d] 100 m).
provided a sensitive method to detect B-cell produc-
tion in ileal PP follicles. There was no detectable
BrdU incorporation in the ileal PP follicular rem-
nants for 3 weeks after dexamethasone treatment
(Figs. 2h and 2i). IHC analysis of 10-20 serial
sections did not reveal BrdU incorporation in the
follicles despite consistent BrdU incorporation in
mucosal crypt epithelium and cells in the interfolli-
cular region. Thus, dexamethasone induced a com-
plete arrest of iPfB-cell proliferation, but small foci
of proliferating iPfB-cells reappeared between 28-35
days postdexamethasone (Fig. 4a) and the size of
this proliferating population increased during the
following 2 months (Figs 4b and 4c). However, the
regenerating follicles were heterogeneous in size
and misshapen when compared with ileal PP folli-
cles from age-matched control lambs (Fig. 2g) and
there was no further increase in follicular size
between days 54-98 posttreatment (Fig. 4c). BrdU
incorporation in normal jejunal PPs revealed a high
level of cell proliferation in mucosal crypt epithe-
lium and the lymphoid follicles, but few cells pro-
liferating in the dome or interfollicular area (Fig. 2d).
Dexamethasone treatment did not inhibit cell pro-
liferation in the crypt epithelium or the lymphoid
follicles despite a marked reduction in follicle size
(Fig. 2e). Following dexamethasone treatment, the
jejunal PP follicles rapidly increased in size andB-CELL DEVELOPMENT IN PEYER’S PATCHES 269
FIGURE 4. Cell proliferation, de-
tected by BrdU incorporation, in the
ileal and jejunal PPs following treat-
ment for 7 days with 2 mg
dexamethasone/kg BW (postdex).
Ileal PP: a (D.32mpostdex); b (D.54--
postdex); and c: (D.98upostdex).
BrdU incorporation was consistently
detected in villus crypt epithelium
and scattered cells in the interfollicu-
lar region (if). Foci of proliferating
cells were detected in follicles (f) on
D.32 posttreatment, but the size of
this proliferating population did not
increase beyond D.54 posttreatment.
The muscularis (ms) is indicated be-
neath the follicles. Jejunal PPs: d
(D.32Mpostdex); e (D.54mpostdex);
and f: (D.98--postdex). A high level of
BrdU incorporation was evident
within the lymphoid follicles (f) at all
times posttreatment and was associ-
ated with a gradual increase in follicle
size. The pattern of BrdU incorpora-
tion in the villus crypt epithelium,
interfollicular region (if), and dome
region (d) remained constant. Magni-
fication: a-f (bar [in a] 350 tm).
cellularity (Figs 2f, 4d, e and f) until they were
similar to follicles in untreated lambs (Fig. 2d).
B-cell Phenotype and Function in
Regenerating PPs
The marked variation in follicle size in the regener-
ating ileal PP (Figs 4a, b, and c) suggested that an
altered B-cell population was developing within the
follicles. Therefore, we examined the normal varia-
tion in ileal and jejunal PP follicular size using a
method to release intact follicles from PPs of young
lambs (Griebel and Ferrari, 1995) and by examining
serial tissue sections of PPs from a 144-day fetal
lamb injected for 1 hr with 20 mg BrdU/kg BW.
From these analyses, it was apparent that lymphoid
follicles in the ileal and jejunal PPs of untreated,
6-10-week-old lambs (Figs 5a and 5b) and a fetal
lamb (Figs 5c and 5d) varied 4-5-fold in size and
also varied in shape. Similar size and shape varia-
tion was observed with both histology and mechan-
ically isolated follicles and the variation in follicle
size occurred despite cell proliferation in all fetal
follicles (Figs 5c and 5d). Thus, variable follicle size
in the regenerating ileal PP may reflect the normal
variation in PP follicular size and the process(es)
responsible for variable follicle size during fetal
development. The phenotype of cells isolated from270 P.J. GRIEBEL et al.
FIGURE 5. Lymphoid follicles in the
PPs of foetuses and young lambs
varied markedly in size. A: Lymphoid
follicles (F) mechanically isolated
from the ileal PP of a 6-week-old
lamb display considerable variation in
size and shape that was independent
of the presence or absence of an
attached dome region (D). Follicles
viewed with phase-contrast micros-
copy. B: Lymphoid follicles (F) iso-
lated from the jejunal PPs display a
similar variation in size and shape
independent of an attached dome re-
gion (D). Follicles viewed with phase-
contrast microscopy. C: All follicles
(F) in the fetal (144-day gestation)
ileal PP had incorporated BrdU but
varied in size. BrdU incorporation
was also evident in the crypt epithe-
lium of the mucosa (m). These obser-
vations were based on the
examination of 45 serial tissue sec-
tions stained for BrdU. d: Fetal jejunal
PP displayed consistent BrdU incor-
poration within follicles (F) and crypt
epithelium (m) but a marked varia-
tion in follicular size and shape.
These observations were based on the
examination of 38 serial tissue sec-
tions stained for BrdU. Magnification:
A, B (bar [in B] 500 tm); magnifica-
tion: c, d (bar [in d] 100 tM).
regenerating ileal and jejunal PP follicles was also
analyzed. These analyses did not reveal significant
differences between cells in regenerating follicles
and cells isolated from PP follicles of untreated
age-matched controls (Table 1).
To evaluated if dexamethasone treatment altered
B-cell function, we examined the production of IgA
and IgG1 PCs in the PPs. The jejunal PPs contain
numerous IgA PCs in the lamina propria adjacent to
villus crypts, in the interfollicular region, the dome
TABLE
Phenotype of Lymphocytes Isolated from Lymphoid Follicles of the Ileal and Jejunal PPs
Phenotype Control
b
Ileal PP follicles
Postdexamethasone Control
Jejunal PP follicles
Postdexamethasone
CD40
d
sIgM
CD51OsigM+
sIgG1
sIgA
CD44hiB-cells
CD4 T-cells
63.2 + 6 4
93.5 + 2 8
2.5+ 18
2.7+ 13
0.3 +03
9.0+ 15
0.42 + 0.2
74.4 + 7.7 53.7 + 7.2 47.8 + 6.1
88.4 + 4.0 44.6 + 7.4 35.0 + 6.6
3.8 + 1.9 28.9 + 8.6 31.2 + 6.9
4.4 + 1.6 20.5 + 8.4 24.8 + 7.3
0.9 + 1.0 16.3 + 7.8 22.0 + 6.2
9.6 + 1.8 2.7 + 1.2 2.8 + 0.8
0.33 + 0.08 14.8 + 5.3 16.3 + 6.1
FACS analyses of cell suspensions prepared from lymphoid follicles, Data presented the S.D. of values from 5, 6-12-week-old lambs. CData presented
the S.D. of values for lambs analyzed between days 42-98 posttreatment. Data pooled after analyses showed significant differences, The CD40 molecule
detected using soluble CD40 ligand-CD8 detected with PE-conjugated rat anti-mouse CD8. Values the /o sIgM B cells that coexpressed CD5. The B-cell
population defined by subtracting CD5 cells (T-cells) from the total CD44 population. The light-scatter gates used for data collection excluded macrophages and
stromal cells from the analyses.B-CELL DEVELOPMENT IN PEYER’S PATCHES 271
region, and within the follicle (Fig. 6d). IgA PCs are
absent in ileal PP follicles, but otherwise have a
distribution similar to the jejunal PPs (Fig. 6a).
Following dexamethasone treatment, there was no
change in the distribution or apparent frequency of
IgA PCs in either the ileal (Figs. 6b and 6c) or jejunal
PPs (Figs. 6e and 6f; Table 1). Similar observations
were made for IgG1 PCs that were located primarily
in the dome region, in the follicles, and in the
interfollicular regions of the jejunal PPs and within
FIGURE 6. Immunoperoxidase staining for IgA revealed a similar distribution of IgA PCs in the PPs in age-matched, untreated lambs
(control) and lambs treated for 7 days with 2 mg dexamethasone/kg BW (postdex), Ileal PP: a (control); b (D.21--postdex);
(D.74--postdex). IgA PCs in the ileal PP were located primarily in the lamina propria, adjacent to the villus crypt, and rare PCs are
seen in the interfollicular (if) and dome (d) region but never in follicles (f). Jejunal PPs: d (control); e (D.21--postdex); f (D.74--postdex).
IgA PCs in the jejunal PP were numerous in the lamina propria, adjacent to the villus crypt, and numerous in the dome region (d),
in the follicle (f), and the interfollicular region (if). f(i) inset: Higher magnification of area outlined in f shows intense cytoplasmic
staining of PCs in the lamina propria and surface staining of the mucosal epithelium. Magnification: a-f (bar [in a] 150 m).272 P.J. GRIEBEL et al.
the dome and interfollicular region of the ileal PP
(data not shown; Table 1). The observations on
follicle structure, B-cell phenotype, and PP function
indicated that the distinct functions performed by
ileal and jejunal PPs remained intact following
dexamethasone treatment.
Depletion of T Lymphocytes in Blood
An acute depletion of greater than 50% blood
T-cells began during and progressed for 1 week
following dexamethasone treatment (Fig. 7b). This T
lymphopenia involved all T-cell subsets and per-
sisted for approximately 6 weeks. The recovery of
circulating T-cell numbers to pretreatment levels
was influenced most by an increase in the predom-
inant T6 TcR-cell population. This occurred between
6-8 weeks posttreatment and followed thymic re-
generation by approximately 3 weeks (Fig. 7). Flow
cytometric analysis of CD44 expression on CD5
hi
cells (T-cells) indicated that thymic involution and
regeneration were linked to changes in blood T-cell
populations. The subpopulation of CD44]CD5hi
cells disappeared during dexamethasone treatment
(Fig. 8; day 01 postdexamethasone) and did not
reappear until 6 weeks posttreatment (Fig. 8; day
40 postdexamethasone). The reappearance of
CD44]CD5hi cells followed thymic regeneration
(Fig. 7a) and preceded the recovery of circulating
T-cells (Fig. 7b). Thus, the temporal order of these
events was consistent with the thymus regenerating
the circulating T-cell population.
Depletion of B Lymphocytes in Blood
Dexamethasone treatment induced an acute and
prolonged decline in blood B-cell numbers and the
composition of this B-cell population was markedly
changed (Fig. 9). In young lambs, approximately
90% blood B-cells (CD40 /) express sIgM (Fig. 9a)
and less than 10% sIgM/B cells express detectable
levels of CD5 (Fig. 8; pretreatment). One week after
dexamethasone treatment less than 20% sIgM/B
cells remained and >90% B cells expressed CD5
(Fig. 8; day 01 postdexamethasone). Furthermore,
the relative contribution of isotype-switched B cells
to the total B-cell population increased to 50%
following dexamethasone treatment (Figs. 9a and
9b). The number of circulating sIgG1 and sIgA B
cells remained relatively constant following dexam-
ethasone treatment, but these B-cell populations
varied widely among individual animals (Fig. 8b).
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FIGURE 7. Dexamethasone treatment (dex) induced a marked
decrease in thymic weight and the number of T lymphocytes in
blood, a: Thymic weights were 20-35% of the normal weight
immediately after dexamethasone treatment (day 0), but 4-5
weeks later there was a complete recovery of thymic mass. Each
data point represents the weight of a single thymus, as a
percentage of BW, and the range of normal thymic weights is
depicted by the rectangle, b: The total number of T lymphocytes
(CD5hi) and all T-lymphocyte subsets (CD4, CD8, 73 TcR
[gamma/delta]) declined markedly following dexamethasone
treatment. The total number of T lymphocytes returned to
pretreatment levels 8 weeks after dexamethasone treatment with
73 T lymphocytes contributing the most to the T-lymphocyte
population. Data presented are the mean + S.D. of values from
varying numbers of lambs (days -7 and 0: n 16; day 98: n 2).
Specificity of the STla mAb for CD5 on B cells was
assessed in two ways. First, CD5hiDu2-104 cells
and CD5Du2-104 cells were sorted with a FAC-
Star cell sorter and cytospots prepared of the two
populations. IHC analyses of cytospots revealed that
CD5hiDu2-104 were 98% CD3 (T-cells) with no
detectable staining for IgM or Ig LC. In contrast,B-CELL DEVELOPMENT IN PEYER’S PATCHES 273
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POST-DEXAMETHASONE
DAY 01
DAY 20
DAY 40
DAY 72
DAY 98
FIGURE 8. Phenotypic analysis of B and T lymphocytes present
in blood before and after dexamethasone treatment (2 mg/kg for
7 days). In young lambs (pretreatment), few B-cells expressed
detectable levels of CD5, but immediately following dexametha-
sone treatment (postdexamethasone: day 01), most sIgM B-cells
expressed a low level of CD5. The predominance of CD5 IgM
B-cells persisted for 14 weeks posttreatment (postdexamethasone
day 98) with a minor subpopulation of CD5-sIgM B-cells. The
changes in CD5 +IgM/B-cell number were reflected in the
lo h CD5 CD44 population. In young lambs (pretreatment), T-cells
h lo (CD5 ) were clearly divided into CD44 (32.4 + 3.8 ’/o of T-cells)
and CD44
hi subpopulations (66.9 + 5.7% of T-cells). During
dexamethasone treatment, the CD44CD5hi subpopulation
(postdexamethasone day 01) was markedly reduced (7.4 + 1.9%
of T-cells) and this reduction persisted for at least 3 weeks
(postdexamethasone day 20). However, 6 weeks after dexam-
ethasone treatment (postdexamethasone day 40), the relative
lo h, frequency of the CD44 CDS subpopulation had recovered
(38.6 + 4.7% of T-cells) to a level comparable to pretreatment
lambs. The X axis presents sIgM expression (column 1) or CD44
expression (column 2) and the Y-axis presents CD5 expression for
the dot scatter plots.
CD51Du2-104 cells were 2% CD3 /, 83% sIgM /,
and 95% Ig LC /. Second, the STla mAb immuno-
precipitated a 67-kD protein from iPfB-cells cocul-
tured with J558L cells transfected with murine
CD40 ligand, but no protein was immunoprecipi-
tated from normal iPfB-cells (data not shown). Few
iPfB-cells bind STla mAb (Table 1), but 60-70%
iPfB-cells bind a detectable level of the STla mAb
following coculture with CD40 ligand (Griebel and
Ferrari, 1995). Thus, present experiments indicate
that in blood, the most steroid-sensitive population
of B-cells were CD5-sIgM and, in the absence of
a functional ileal PP, this population remained se-
verely depleted. A small number of CD5-sIgM
B-cells were evident between 9-10 weeks posttreat-
ment and this population increased a little during
the next 4 weeks (Fig. 8; day 98 postdexamethasone;
Fig. 9a). Thus, a return in iPfB-cell proliferation was
followed 4 weeks later by the appearance of a
limited number of CD5-sIgM B-cells in blood
(Figs. 4a and 9a). The prolonged B lymphopaenia
was in marked contrast to the recovery in circulating
T-cell number (Fig. 8). Finally, a transient neutro-
philia during dexamethasone treatment was the
only alteration in blood polymorphonuclear leuko-
cyte, monocyte, and red blood cell populations
observed throughout these experiments (data not
shown). These observations, together with thymic
regeneration, indicate that hematopoiesis in bone
marrow was not altered by dexamethasone. Thus, it
seems unlikely that altered B lymphopoiesis in the
bone marrow could explain the prolonged B lym-
phopenia in blood.
DISCUSSION
The present experiments clearly demonstrated that,
as expected for a population of immature lympho-
cytes, the B-cells in lymphoid follicles of the ileal PP
were very corticosteroid-sensitive (Fig. 1). Dexa-
methasone treatment completely disrupted the
function of the ileal PP (Fig. 2h), but had relatively
minor effects on the jejunal PP (Figs. 2e, 2f, 6e and
6f). Extensive follicular involution in the ileal PP
after treatment with dexamethasone for 72 hr (data
not shown) was consistent with a direct cytolytic
effect on iPfB-cells. However, it remains to be
determined if dexamethasone also acted indirectly
by disrupting signals that supported iPfB-cell
growth despite the survival of many mesenchymal
cells in the follicular remnants (Fig. 3). Clearly,274 P.J. GRIEBEL et al.
corticosteroid treatment inhibited much more effec-
tively the T-cell-independent proliferation of iPfB-
cells than the T-cell-dependent development of
B-cells in the jejunal PPs (Griebel and Ferrari, 1994;
Griebel and Ferrari, 1995). Thus, B-cell development
in these two PP was shown to be distinct.
The absence of detectable iPfB-cell proliferation
for a 4-week period did not result in a permanent
arrest of iPfB-cell development (Fig. 4). Thus, sus-
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FIGURE 9. There was a sharp decline in total B-cell numbers in
blood following dexamethasone treatment (2 mg/kg for 7 days)
and this B lymphopenia persisted throughout the experiment, a:
One week following dexamethasone treatment, the total number
of B-cells (CD40 /) in blood had declined to 30% of pretreatment
values. The sIgM B-cells (sIgM accounted for 90% of B-cells in
blood prior to dexamethasone treatment, but less than 50% follow-
ing dexamethasone treatment. Finally, CD5 sIgM B-cells
(CD5 sIgM were a minor population in young lambs, but more
than 90% sIgM B-cells expressed a detectable level of CD5 fol-
lowing dexamethasone treatment. A detectable level of CD5-
sIgM B-cells were apparent 80 days posttreatment and then grad-
ually increased, b: Dexamethasone treatment did not significantly
alter the number of sIgG B-cells (sIgG or sIgA B-cells (sIgA
in blood. Considerable variation in isotype-switched B-cell number
was noted within and among experimental groups. Following dex-
amethasone treatment, the isotype-switched B-cells comprised
50% of the total B-cell population. Data presented are the mean +
S.D. of values from varying numbers of lambs (days -7 and 0: n
16; day 98: n 2; see Fig. 7a).
tained self-renewing proliferation is not essential to
maintain the iPfB-cell population as was previously
suggested by in vitro experiments (Griebel and
Ferrari, 1994). The involuted follicles may have
been repopulated by B-cells surviving within the
ileal PP follicles or dome region (Fig. 3d) or B-cells
circulating in the blood (Fig. 9). If either intrafollic-
ular or dome region B-cells were the source of the
proliferating iPfB-cells, this would imply the exist-
ence of a functionally distinct, steroid-resistant stem
B-cell that can give rise to the rapidly dividing,
steroid-sensitive iPfB-cells. Alternatively, it could be
postulated that, as for the thymus, the bone marrow
functions as the primary source of B-cell progenitors
that then undergo further development in the
unique microenvironment of the ileal PP follicles.
The present experiments could not determine the
source of B-cells in regenerating ileal PP follicles.
However, it was evident that the regenerating ileal
PP maintained the unique function of this tissue.
This conclusion was supported by the analyses of
follicle structure (Fig. 5), B-cell phenotype (Table 1),
and PP function (Fig. 6). Finally, the limited regen-
eration of ileal PP follicles (Fig. 4c) may also reflect
normal ileal PP development because ileal PP invo-
lution usually begins at 3-4 months of age (Rey-
nolds and Morris, 1983).
It is difficult to explain the prolonged quiescent
period in B-cell production if the ileal PP follicles
were regenerated by intrafollicular B-cells. The de-
tection of BrdU incorporation in individual mucosal
epithelial cells and interfollicular cells (Figs. 2h and
2i) indicated that limited sensitivity of BrdU detec-
tion could not explain the absence of proliferating
iPfB-cells. Alternatively, despite the survival of fol-
licular architecture (Fig. 3), the dexamethasone
treatment may have disrupted nonlymphoid
stromal-cell functions that support iPfB-cell prolif-
eration (Griebel and Ferrari, 1994). Dexamethasone
can inhibit the production of diverse cytokines
(Bettens et al., 1984; Culpepper and Lee, 1985; Lee
et al., 1988; Waage and Bakke, 1988) and alter the
functional state of a wide variety of cells (Cupps and
Fauci, 1982). Thus, if time were required to regen-
erate functional stromal cells, then it may have
limited iPfB-cell proliferation. Alternatively, the de-
lay in ileal PP regeneration may also be explained by
the time required for sIgM B-cell differentiation in
bone marrow and then the homing of naive B-cells
to the ileal PP. An analysis of the frequency of Ig
V gene somatic mutation (Reynaud et al., 1995) in
B-cells of regenerated ileal PP follicles may revealB-CELL DEVELOPMENT IN PEYER’S PATCHES 275
the source of stem B-cells if the assumption applies
that bone-marrow-derived B-cells would be unmu-
tated and an intrafollicular stem cell was mutated
prior to dexamethasone treatment. Alternatively,
transplantation of involuted ileal PP follicles into
SCID mice may reveal intrafollicular stem B-cells if
all follicular elements essential for the support of
iPfB-cell proliferation survived dexamethasone
treatment and the immigration of stromal-cell ele-
ments was not integral to PP regeneration.
Previous experiments, using surgical extirpation
of the ileal PP in fetal and new-born lambs, indi-
cated that the ileal PP was the major source of
B-cells in young lambs (Reynolds et al., 1985;
Gerber et al., 1986). This implied that bone marrow
played a minor role in B lymphopoiesis or that the
ileal PP provided an essential environment for B-cell
development. The effects of dexamethasone-
induced involution of the ileal PP were similar to
surgical extirpation (Gerber et al., 1986) with both a
severe and prolonged B lymphopenia (Fig. 9) and no
disruption of gut-associated IgA PC production (Ta-
ble 1" Fig. 6). The present experiments clearly
indicated that in the absence of a functional ileal
PP, there were no other sources of circulating
CD5-sIgM
/ B-cells (Fig. 9a) and the resumption of a
reduced level of iPfB-cell proliferation (Fig. 4a) was
followed by the reappearance of a small number of
CD5-sIgM B-cells in blood (Fig. 9a). The B lym-
phopaenia observed 98 days postdexamethasone
was even more dramatic when compared to the
number of B-cells (2.5-3.0x 106 cells/ml blood)
reported for 4-5-month-old lambs (Hein et al.,
1990). Thus, the low level of iPfB-cell proliferation
in the regenerating ileal PP was not capable of
effectively generating circulating CD5-sIgM B-
cells. In contrast, the number of CD5 sIgM B-cells
remained relatively constant despite the presence or
absence of a functional ileal PP (Fig. 9a), indicating
that the generation or maintenance of CD5 B-cells
was not linked to the ileal PP. This is consistent with
the paucity of CD5 sIgM B-cells in the ileal PP
and the presence of numerous CD5 sIgM B-cells
in the jejunal PP (Table 1). Thus, as suggested by in
vitro experiments, the expression of CD5 on sheep
B-cells may simply be an indication of T-cell-
dependent B-cell activation (Griebel and Ferrari,
1995). The persistence of CD5 B-cells in sheep
would be consistent with observations in mice
and humans, which indicated that corticosteroid
treatment does not prevent secondary, T-cell-
dependent, B-cell responses (Cupps and Fauci,
1982).
A profound depletion of circulating B-cells
(>90%) and T-cells was also observed during pro-
longed dexamethasone treatment of young calves
(Oldham and Howard, 1992). In these experiments,
a similar dosage of dexamethasone was used and
the resulting B lymphopaenia indicates that corti-
costeroid sensitivity may be characteristic for ileal
PP B-cells in young ruminants and possibly other
species where this lymphoid tissue is prominent.
Consistent with this conclusion is the observation
that the age of an animal is an important factor in
determining the effect of dexamethasone treatment
on blood lymphocytes populations (Oldham and
Howard, 1992). From the present experiments, it is
clear that dexamethasone treatment can disrupt
lymphocyte production in both the thymus and ileal
PP (Fig. 1) and marked changes in the circulating
lymphocyte populations follow as a natural conse-
quence (Fig. 8). Thus, the present model of
dexamethasone-induced involution of the ileal PP
may provide a means to identify in which species
the ileal PP functions as a primary source of circu-
lating B-cells. Finally, previous in vitro observations
were used to define various species as either
corticosteroid-sensitive or corticosteroid-resistant
(Clamen et al., 1971), but these definitions have
ignored the fact that B-cell development may vary
significantly in young animals of different species.
In conclusion, the present experiments clearly
demonstrated that ileal PP follicles contain a popu-
lation of steroid-sensitive B-cells and there may also
be an intrafollicular steroid-resistant B-stem-cell
population. In young lambs, the ileal PP was essen-
tial for the generation of CD5-sIgM B-cells, but
T-cell-dependent B-cell development can continue
in other lymphoid tissues. Furthermore, during the
absence of a functional ileal PP CD5+sIgM
/ B-cell
numbers remain constant (Fig. 9). Thus,
dexamethasone-induced involution of the ileal PP
may provide a good model with which to study
humoral immune responses when the "conven-
tional" or CD5- B-cell population is severely de-
pleted. Also, it may be possible to determine if
sheep CD5/sIgM B-cells represent, as in mice
(Kantor and Herzenberg, 1993), a functionally dis-
tinct lineage of B-cells or B-cells that have res-
ponded to T-cell-dependent antigens (Griebel and
Ferrari, 1995). If the latter is true, then primary
humoral immune responses may be compromized in
the absence of CD5-sIgM/B-cells, but secondary276 P.J. GRIEBEL et al.
humoral immune responses should remain intact.
Experiments are in progress to test this hypothesis
and determine if dexamethasone involution of the
ileal PP is a simple method to produce lambs with a
humoral immune deficiency.
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